3DeviTS,L e e I,HuttemannM,KumarA,NantwiKD,Singh LP.TXNIPlinksinnatehostdefensemechanismstooxidativestressandinflammationinretinalMullergliaunderchronichyperglycemia:im plicationsfordiabeticretinopathy[J].ExpDiabetesRes.2012;2012:438-238.
5L a z a r e v i c G ,A n t i c S ,C v e t k o v i c T ,e t a l . A p h y s i c a lactivityprogrammeanditseffectsoninsulinresistanceandoxidativedefenseinobesem alepatientsw ithtype2 d iab etesm ellitu s[J].DiabetesMetab,2006,32(6):583-590.
2Sowers JR, Epstein M, Frohich ED. Diabetes, hypertension, and cardiovascular disease : an update. Hypertension, 2001, 37 : 1053- 1059.
3Galderisi M. Diastolic dysfunction and diabetic cardiomyopathy; evaluation by Doppler echocardiography. J Am Coll Cardiol, 2006, 48 : 1548- 1551.
4Chen S, Khan ZA, Karmazyn M, et al. Role of endothelin- 1, sodium, hydrogen exchanger-1 and mitogen activated protein kinase (MAPK) activation in glucose- induced cardiomyocyte hypertrophy. Diabetes Metab Res Rev, 2007, 23 : 356 - 367.
5Tang M, Zhong M, Shang Y, et al. Differential regulation of collagen types ! and III expression in cardiac fibroblasts by AGEs through TRB3/MAPK signaling pathway. Cell Mol Life Sci, 2008, 65 : 2924 - 2932.
6Herrero P, Peterson LR, McGill JB, et al. Increased myocardial fatty acid metabolism in patients with type I diabetes mellitus. J Am Coil Cardiol, 2006, 47 : 598 -604.
7van Herpen NA, Schrauwen-Hinderling VB. Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol Behav, 2008, 94 : 231 -241.
8Zhon G, Li X, Hein DW, et al. Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart. J Am Coil Cardiol, 2008, 52 : 655 - 666.
9Watanabe K, Tbandavarayan RA, Gurusamy N, et al. Role of 14-3-3 protein and oxidative stress in diabetic cardiomyopathy. Acta Physiol Hung, 2009, 96 : 277 -287.
10Kaminski KA, Szepietowska B, Bonda T, et al. CCN2 protein is an announcing marker for cardiac remodeling following STZ-induced moderate hyperglycemia in mice. Pharmacol Rep, 2009, 61 : 496-503.
